Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

150 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Blockade of HLA Antibody-Triggered Classical Complement Activation in Sera From Subjects Dosed With the Anti-C1s Monoclonal Antibody TNT009-Results from a Randomized First-in-Human Phase 1 Trial.
Mühlbacher J, Jilma B, Wahrmann M, Bartko J, Eskandary F, Schörgenhofer C, Schwameis M, Parry GC, Gilbert JC, Panicker S, Böhmig GA. Mühlbacher J, et al. Among authors: bartko j. Transplantation. 2017 Oct;101(10):2410-2418. doi: 10.1097/TP.0000000000001804. Transplantation. 2017. PMID: 28926521 Free PMC article. Clinical Trial.
A Randomized, First-in-Human, Healthy Volunteer Trial of sutimlimab, a Humanized Antibody for the Specific Inhibition of the Classical Complement Pathway.
Bartko J, Schoergenhofer C, Schwameis M, Firbas C, Beliveau M, Chang C, Marier JF, Nix D, Gilbert JC, Panicker S, Jilma B. Bartko J, et al. Clin Pharmacol Ther. 2018 Oct;104(4):655-663. doi: 10.1002/cpt.1111. Epub 2018 Jul 13. Clin Pharmacol Ther. 2018. PMID: 29737533 Free PMC article. Clinical Trial.
Inhibition of complement C1s improves severe hemolytic anemia in cold agglutinin disease: a first-in-human trial.
Jäger U, D'Sa S, Schörgenhofer C, Bartko J, Derhaschnig U, Sillaber C, Jilma-Stohlawetz P, Fillitz M, Schenk T, Patou G, Panicker S, Parry GC, Gilbert JC, Jilma B. Jäger U, et al. Among authors: bartko j. Blood. 2019 Feb 28;133(9):893-901. doi: 10.1182/blood-2018-06-856930. Epub 2018 Dec 17. Blood. 2019. PMID: 30559259 Free PMC article. Clinical Trial.
Dexamethasone inhibits endotoxin-induced coagulopathy in human lungs.
Bartko J, Schoergenhofer C, Schwameis M, Buchtele N, Wojta J, Schabbauer G, Stiebellehner L, Jilma B. Bartko J, et al. J Thromb Haemost. 2016 Dec;14(12):2471-2477. doi: 10.1111/jth.13504. Epub 2016 Oct 24. J Thromb Haemost. 2016. PMID: 27622544 Free PMC article. Clinical Trial.
Randomized, Double-Blind, Placebo-Controlled, Single-Ascending-Dose Study of the Penetration of a Monoclonal Antibody Combination (ASN100) Targeting Staphylococcus aureus Cytotoxins in the Lung Epithelial Lining Fluid of Healthy Volunteers.
Magyarics Z, Leslie F, Bartko J, Rouha H, Luperchio S, Schörgenhofer C, Schwameis M, Derhaschnig U, Lagler H, Stiebellehner L, Firbas C, Weber S, Campanaro E, Jilma B, Nagy E, Stevens C. Magyarics Z, et al. Among authors: bartko j. Antimicrob Agents Chemother. 2019 Jul 25;63(8):e00350-19. doi: 10.1128/AAC.00350-19. Print 2019 Aug. Antimicrob Agents Chemother. 2019. PMID: 31138568 Free PMC article. Clinical Trial.
Safety of a universal, virus-inactivated and prion-depleted, pharmaceutical-quality plasma: a randomized, double-blind, clinical trial in healthy volunteers.
Jilma-Stohlawetz P, Kursten FW, Walasek C, Horvath M, Leitner G, List J, Quehenberger P, Schwameis M, Bartko J, Jilma B. Jilma-Stohlawetz P, et al. Among authors: bartko j. Transfusion. 2011 Jun;51(6):1228-40. doi: 10.1111/j.1537-2995.2010.03005.x. Epub 2011 Feb 18. Transfusion. 2011. PMID: 21332722 Clinical Trial.
150 results